Vical announces Phase 2 efficacy trial for antifungal VL-2397

Vical announces Phase 2 efficacy trial for antifungal VL-2397Fri, 10/06/2017 - 16:50News blog

Source: The Aspergillus Website - updates - October 6, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news